Inventor

Supriya Gupta

Inventor
Sunnyvale, CA, US

Overview

18→
Patents
2009–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
B82YSpecific uses or applications of nanostructures13%
C08BPolysaccharides13%
C08LCompositions of macromolecular compounds13%
C07KPeptides10%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
10,987,313Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof202110,973,769Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof202110,758,616Pre-mixed, ready-to-use pharmaceutical compositions20209,944,720Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof20189,549,994'Compositions of nicardipine and sulfoalkylated β-cyclodextrin'20179,370,586'Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions'20169,364,564'Pre-mixed, ready-to-use pharmaceutical compositions'20169,163,093'Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof'20159,045,551'Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof'20158,466,178'Pre-mixed, ready-to-use pharmaceutical compositions'20138,465,739'Stable aqueous pharmaceutical formulations of daclizumab antibodies'20138,466,179'Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions'20138,455,524'Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions'20138,298,530'Stable lyophilized pharmaceutical formulation of IgG antibodies'20127,659,291'Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions'20107,659,290'Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions'20107,612,102'Pre-mixed, ready-to-use pharmaceutical compositions'20097,592,004'Stable lyophilized pharmaceutical formulation of IgG antibodies'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2020Patents assigned to EKR THERAPEUTICS INC (8)· patent assignee history
2009–2018Based in Sunnyvale, CA, US· patent location history
2012–2016Patents assigned to GUPTA SUPRIYA (6)· patent assignee history
2013–2016Patents assigned to ZAMIRI CAMELLIA (4)· patent assignee history
2013–2016Patents assigned to DUNCAN MICHELLE RENEE (3)· patent assignee history
2015–2018Patents assigned to ABBVIE INC (3)· patent assignee history
2020Based in Waverly, IA, US· patent location history
2021Based in Hayward, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EKR THERAPEUTICS INC82009–2020
GUPTA SUPRIYAself62012–2016
ZAMIRI CAMELLIA42013–2016
ABBVIE INC32015–2018
DUNCAN MICHELLE RENEE32013–2016
Locations
LocationPatentsSpan
Sunnyvale, California, US152009–2018
Hayward, California, US22021
Waverly, IA, US12020